BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28637186)

  • 21. Methylation-dependent and -independent genomic targeting principles of the MBD protein family.
    Baubec T; Ivánek R; Lienert F; Schübeler D
    Cell; 2013 Apr; 153(2):480-92. PubMed ID: 23582333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyl-CpG binding domain (MBD)2/3 specifically recognizes and binds to the genomic mCpG site with a β-sheet in the MBD to affect embryonic development in Bombyx mori.
    Fu TY; Ji SS; Tian YL; Lin YG; Chen YM; Zhong QE; Zheng SC; Xu GF
    Insect Sci; 2023 Dec; 30(6):1607-1621. PubMed ID: 36915030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA looping by two 5-methylcytosine-binding proteins quantified using nanofluidic devices.
    Liu M; Movahed S; Dangi S; Pan H; Kaur P; Bilinovich SM; Faison EM; Leighton GO; Wang H; Williams DC; Riehn R
    Epigenetics Chromatin; 2020 Mar; 13(1):18. PubMed ID: 32178718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants.
    Xu C; Liu K; Lei M; Yang A; Li Y; Hughes TR; Min J
    Structure; 2018 Jan; 26(1):85-95.e3. PubMed ID: 29276034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methyl-CpG/MBD2 Interaction Requires Minimum Separation and Exhibits Minimal Sequence Specificity.
    Moreland B; Oman K; Curfman J; Yan P; Bundschuh R
    Biophys J; 2016 Dec; 111(12):2551-2561. PubMed ID: 28002732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells.
    Yu X; Azzo A; Bilinovich SM; Li X; Dozmorov M; Kurita R; Nakamura Y; Williams DC; Ginder GD
    Haematologica; 2019 Dec; 104(12):2361-2371. PubMed ID: 31004025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG dinucleotide positioning patterns determine the binding affinity of methyl-binding domain to nucleosomes.
    Mendonca A; Sanchez OF; Liu W; Li Z; Yuan C
    Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):713-720. PubMed ID: 28377300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of a family of mammalian methyl-CpG binding proteins.
    Hendrich B; Bird A
    Mol Cell Biol; 1998 Nov; 18(11):6538-47. PubMed ID: 9774669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of the DNA methylation system component MBD2 by protein arginine methylation.
    Tan CP; Nakielny S
    Mol Cell Biol; 2006 Oct; 26(19):7224-35. PubMed ID: 16980624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.
    Saito M; Ishikawa F
    J Biol Chem; 2002 Sep; 277(38):35434-9. PubMed ID: 12124384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Links between DNA methylation and nucleosome occupancy in the human genome.
    Collings CK; Anderson JN
    Epigenetics Chromatin; 2017; 10():18. PubMed ID: 28413449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The solution structure of the domain from MeCP2 that binds to methylated DNA.
    Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
    J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Chemical Probes Targeting MBD2.
    Erdmann D; Contreras J; Le Meur RA; Vitorge B; Saverat V; Tafit A; Jallet C; Cadet-Daniel V; Bon C; Phansavath P; Ratovelomanana-Vidal V; Jeltsch A; Vichier-Guerre S; Guijarro JI; Arimondo PB
    ACS Chem Biol; 2022 Jun; 17(6):1415-1426. PubMed ID: 35649238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting the roles of MBD2 isoforms and domains in regulating NuRD complex function during cellular differentiation.
    Schmolka N; Karemaker ID; Cardoso da Silva R; Recchia DC; Spegg V; Bhaskaran J; Teske M; de Wagenaar NP; Altmeyer M; Baubec T
    Nat Commun; 2023 Jun; 14(1):3848. PubMed ID: 37385984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics study of the recognition of dimethylated CpG sites by MBD1 protein.
    Bianchi C; Zangi R
    J Chem Inf Model; 2015 Mar; 55(3):636-44. PubMed ID: 25658035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex.
    Gnanapragasam MN; Scarsdale JN; Amaya ML; Webb HD; Desai MA; Walavalkar NM; Wang SZ; Zu Zhu S; Ginder GD; Williams DC
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7487-92. PubMed ID: 21490301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic and thermodynamic evidence for flipping of a methyl-CpG binding domain on methylated DNA.
    Inomata K; Ohki I; Tochio H; Fujiwara K; Hiroaki H; Shirakawa M
    Biochemistry; 2008 Mar; 47(10):3266-71. PubMed ID: 18266325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. iTRAQ-based chromatin proteomic screen reveals CHD4-dependent recruitment of MBD2 to sites of DNA damage.
    Sun Y; Yang Y; Shen H; Huang M; Wang Z; Liu Y; Zhang H; Tang TS; Guo C
    Biochem Biophys Res Commun; 2016 Feb; 471(1):142-8. PubMed ID: 26827827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.